Early trial probes adding old drug to tough leukemia fight in kids
NCT ID NCT03568994
Summary
This early study tested whether a drug called atovaquone could be safely given alongside standard chemotherapy to children and young adults newly diagnosed with acute myeloid leukemia (AML). Researchers wanted to see if patients could tolerate the combined treatment and to measure how much of the atovaquone stayed in their blood. The main goal was to gather information on safety and dosing to see if this combination is worth studying further.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baylor College of Medicine - Texas Childrens Hospital
Houston, Texas, 77030, United States
-
Johns Hopkins Medicine
Baltimore, Maryland, 21205, United States
Conditions
Explore the condition pages connected to this study.